These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29371192)

  • 1. Novel approach to vancomycin level monitoring: Impact of a multidisciplinary monitoring system on timing of vancomycin levels.
    Peyko V; Friedman-Jakubovics M
    Am J Health Syst Pharm; 2018 Feb; 75(3):121-126. PubMed ID: 29371192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin.
    Masuda N; Maiguma T; Komoto A; Haruki Y; Sugiyama T; Kondo S; Teshima D
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients.
    Hammond DA; James TB; Atkinson LN; Painter JT; Lusardi K
    Crit Care Nurse; 2018 Feb; 38(1):24-28. PubMed ID: 29437075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders.
    Traugott KA; Maxwell PR; Green K; Frei C; Lewis JS
    Am J Health Syst Pharm; 2011 Feb; 68(4):347-52. PubMed ID: 21289330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Nursing Education on the Proportion of Appropriately Drawn Vancomycin Trough Concentrations.
    Coleman LK; Wilson AS
    J Pharm Pract; 2016 Oct; 29(5):472-4. PubMed ID: 25613053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automating Vancomycin Monitoring to Improve Patient Safety.
    Mishra V; Chouinard M; Keiser J; Wagner B; Yen MS; Banas C; Dow A
    Jt Comm J Qual Patient Saf; 2019 Nov; 45(11):757-762. PubMed ID: 31526711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What proportion of vancomycin trough levels are drawn too early?: frequency and impact on clinical actions.
    Morrison AP; Melanson SE; Carty MG; Bates DW; Szumita PM; Tanasijevic MJ
    Am J Clin Pathol; 2012 Mar; 137(3):472-8. PubMed ID: 22338061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Pediatric-Specific Vancomycin Dosing Guidelines: A Quality Improvement Initiative.
    Miloslavsky M; Galler MF; Moawad I; Actis J; Cummings BM; El Saleeby CM
    Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the correct timing of vancomycin level collection utilizing a vancomycin medication administration record (MAR) level order.
    Shah S; Rouse GE; McManus D; Tichy EM; DeVaux L; Hutchins L; Topal JE
    Int J Med Inform; 2020 Nov; 143():104249. PubMed ID: 32957015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.
    Kondo M; Nakagawa S; Orii S; Itohara K; Sugimoto M; Omura T; Sato Y; Imai S; Yonezawa A; Nakagawa T; Matsubara K
    Biol Pharm Bull; 2020; 43(10):1463-1468. PubMed ID: 32999156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol versus Nonprotocol Dosing of Vancomycin in Neonates: A Single Center Evaluation of Steady State Trough Levels.
    Schwartz ML; Wrobel J; Huntley J; Zeilmann C
    Am J Perinatol; 2016 Jun; 33(7):678-82. PubMed ID: 26862722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
    Prybylski JP
    Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study.
    Lu H; Duan L; Yu Y; Li J; Shi L; Xue S; Zhang Q; Zhou Q; Zhu C; Shang E; Yan X; Tang L
    J Chemother; 2022 Nov; 34(7):446-458. PubMed ID: 35773225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of vancomycin therapeutic usage and trough levels monitoring.
    Kabbara WK; El-Khoury G; Chamas NR
    J Infect Dev Ctries; 2018 Nov; 12(11):978-984. PubMed ID: 32012127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.